FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

José Lucas

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Phenomena

Procedures

Immunohistochemistry

Physiology

Co-author Network

Publications

TOP 3
Jesús F Torres-Peraza; Raquel Martín-Ibáñez; Amaya Sanz-Rodríguez; Josep M Canals; Tobias Engel; Miriam Esgleas; M Rosario Fernández-Fernández; David C Henshall; José J Lucas
Protective neuronal induction of ATF5 in endoplasmic reticulum stress induced by status epilepticus.
Olga Carretón; Silvia Ginés; Albert Giralt; José J Lucas; Jesús F Torres-Peraza; Verónica Brito; Josep M Canals; Jordi Alberch
Age-dependent decline of motor neocortex but not hippocampal performance in heterozygous BDNF mice correlates with a decrease of cortical PSD-95 but an increase of hippocampal TrkB levels.
Ana Saavedra; Xavier Xifró; Jian Xu; Laura Rué; Jordi Alberch; Albert Giralt; Paul J Lombroso; José J Lucas; Zaira Ortega; Esther Pérez-Navarro
Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of José Lucas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jesús F Torres-Peraza; Raquel Martín-Ibáñez; Amaya Sanz-Rodríguez; Josep M Canals; Tobias Engel; Miriam Esgleas; M Rosario Fernández-Fernández; David C Henshall; José J Lucas
Protective neuronal induction of ATF5 in endoplasmic reticulum stress induced by status epilepticus.
Brain : a journal of neurology 2013;136(Pt 4):1161-76.
2012: Olga Carretón; Silvia Ginés; Albert Giralt; José J Lucas; Jesús F Torres-Peraza; Verónica Brito; Josep M Canals; Jordi Alberch
Age-dependent decline of motor neocortex but not hippocampal performance in heterozygous BDNF mice correlates with a decrease of cortical PSD-95 but an increase of hippocampal TrkB levels.
Experimental neurology 2012;237(2):335-45.
2011: Ana Saavedra; Xavier Xifró; Jian Xu; Laura Rué; Jordi Alberch; Albert Giralt; Paul J Lombroso; José J Lucas; Zaira Ortega; Esther Pérez-Navarro
Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(22):8150-62.
2010: Félix Hernández; Elena Gómez de Barreda; Almudena Fuster-Matanzo; José J Lucas; Jesús Avila
GSK3: a possible link between beta amyloid peptide and tau protein.
Experimental neurology 2010;223(2):322-5.
2010: Elena Gómez de Barreda; Mar Pérez; Pilar Gómez-Ramos; Javier de Cristobal; Patricia Martín-Maestro; Asunción Morán; Hana N Dawson; Michael P Vitek; José J Lucas; Félix Hernández; Jesús Avila
Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits.
Neurobiology of disease 2010;37(3):622-9.
2010: A Saavedra; Juan M García-Martínez; Xavier Xifró; A Giralt; Jesús F Torres-Peraza; Josep M Canals; Miguel Díaz-Hernández; José J Lucas; Jordi Alberch; Esther Pérez-Navarro
PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
Cell death and differentiation 2010;17(2):324-35.
2010: Jesús Avila; Elena Gómez de Barreda; Tobias Engel; Mar Pérez; Patricia Martín-Maestro; Almudena Fuster-Matanzo; Paloma Goñi-Oliver; José J Lucas; Félix Hernández
Tau kinase I overexpression induces dentate gyrus degeneration.
Neuro-degenerative diseases 2010;7(1-3):13-5.
2009: Xavier Xifró; Albert Giralt; Ana Saavedra; Juan M García-Martínez; Miguel Díaz-Hernández; José J Lucas; Jordi Alberch; Esther Pérez-Navarro
Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.
Neurobiology of disease 2009;36(3):461-9.
2009: Félix Hernández; Elena Gómez de Barreda; Almudena Fuster-Matanzo; Paloma Goñi-Oliver; José J Lucas; Jesús Avila
The role of GSK3 in Alzheimer disease.
Brain research bulletin 2009;80(4-5):248-50.
2009: Miguel Díaz-Hernández; María Díez-Zaera; Jesús Sánchez-Nogueiro; Rosa Gómez-Villafuertes; Josep M Canals; Jordi Alberch; M Teresa Miras-Portugal; José J Lucas
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(6):1893-906.
2008: Tobias Engel; P Goñi-Oliver; P Gomez-Ramos; María A Morán; José J Lucas; Jesús Avila; Félix Hernández
Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.
Neuroscience 2008;157(4):772-80.
2008: Tobias Engel; P Goñi-Oliver; E Gómez de Barreda; José J Lucas; Félix Hernández; Jesús Avila
Lithium, a potential protective drug in Alzheimer's disease.
Neuro-degenerative diseases 2008;5(3-4):247-9.
2007: Z Ortega; Miguel Díaz-Hernández; José J Lucas
Is the ubiquitin-proteasome system impaired in Huntington's disease?
Cellular and molecular life sciences : CMLS 2007;64(17):2245-57.
2007: Juan M García-Martínez; Esther Pérez-Navarro; Xavier Xifró; Josep M Canals; Miguel Díaz-Hernández; Yaël Trioulier; Emmanuel Brouillet; José J Lucas; Jordi Alberch
BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
Journal of neuroscience research 2007;85(12):2756-69.
2007: Paloma Goñi-Oliver; José J Lucas; Jesús Avila; Félix Hernández
N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation.
The Journal of biological chemistry 2007;282(31):22406-13.
2007: Tobias Engel; José J Lucas; Félix Hernández; Jesús Avila
A mouse model to study tau pathology related with tau phosphorylation and assembly.
Journal of the neurological sciences 2007;257(1-2):250-4.
2007: Raquel Gómez-Sintes; Félix Hernández; Analía Bortolozzi; Francesc Artigas; Jesús Avila; paola francesca zaratin; Jean Pierre Gotteland; José J Lucas
Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice.
The EMBO journal 2007;26(11):2743-54.
2007: Adriana G Valera; Miguel Díaz-Hernández; Félix Hernández; José J Lucas
Testing the possible inhibition of proteasome by direct interaction with ubiquitylated and aggregated huntingtin.
Brain research bulletin 2007;72(2-3):121-3.
2007: Claudie Hooper; Vladimir Markevich; Florian Plattner; Richard Killick; Emma Schofield; Tobias Engel; Felix Hernandez; Brian H Anderton; Kobi Rosenblum; T V P Bliss; Sam F Cooke; Jesús Avila; José J Lucas; peter giese; John Stephenson; Simon Lovestone
Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.
The European journal of neuroscience 2007;25(1):81-6.
2006: Tobias Engel; Paloma Goñi-Oliver; José J Lucas; Jesús Avila; Félix Hernández
Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Journal of neurochemistry 2006;99(6):1445-55.
2006: Miguel Díaz-Hernández; Adriana G Valera; María A Morán; Pilar Gómez-Ramos; Beatriz Alvarez-Castelao; José G Castaño; Félix Hernández; José J Lucas
Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
Journal of neurochemistry 2006;98(5):1585-96.
2006: Tobias Engel; José J Lucas; Pilar Gómez-Ramos; María A Moran; Jesús Avila; Félix Hernández
Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration.
Neurobiology of aging 2006;27(9):1258-68.
2006: Tobias Engel; Félix Hernández; Jesús Avila; José J Lucas
Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(19):5083-90.
2006: Silvia Ginés; Miquel Bosch; Sònia Marco; Núria Gavaldà; Miguel Díaz-Hernández; José J Lucas; Josep M Canals; Jordi Alberch
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
The European journal of neuroscience 2006;23(3):649-58.
2005: Adriana G Valera; Miguel Díaz-Hernández; Félix Hernández; Z Ortega; José J Lucas
The ubiquitin-proteasome system in Huntington's disease.
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2005;11(6):583-94.
2005: Miguel Díaz-Hernández; Jesús F Torres-Peraza; Alejandro Salvatori-Abarca; María A Morán; Pilar Gómez-Ramos; Jordi Alberch; José J Lucas
Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(42):9773-81.
2004: Miguel Díaz-Hernández; Fernando Moreno-Herrero; Pilar Gómez-Ramos; María A Morán; Isidro Ferrer; Arturo M Baró; Jesús Avila; Félix Hernández; José J Lucas
Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(42):9361-71.
2004: Jesús Avila; Mar Pérez; José J Lucas; Alberto Gómez-Ramos; Ismael Santa-María; Francisco Moreno; Mark A. Smith; George Perry; Félix Hernández
Assembly in vitro of tau protein and its implications in Alzheimer's disease.
Current Alzheimer research 2004;1(2):97-101.
2004: Isidro Ferrer; Begoña Martín; José G Castaño; José J Lucas; Dolores Moreno; Montse Olivé
Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis.
Journal of neuropathology and experimental neurology 2004;63(5):484-98.
2004: Jesús Avila; José J Lucas; Mar Perez; Felix Hernandez
Role of tau protein in both physiological and pathological conditions.
Physiological reviews 2004;84(2):361-84.
2004: Félix Hernández; Miguel Díaz-Hernández; Jesús Avila; José J Lucas
Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo.
Trends in neurosciences 2004;27(2):66-9.
2004: Félix Hernández; Mar Pérez; José J Lucas; Ana Mata; Ratan Bhat; Jesús Avila
Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease.
The Journal of biological chemistry 2004;279(5):3801-6.
2004: Miguel Díaz-Hernández; Ester Martin-Aparicio; Jesús Avila; Félix Hernández; José J Lucas
Enhanced induction of the immunoproteasome by interferon gamma in neurons expressing mutant Huntingtin.
Neurotoxicity research 2004;6(6):463-8.
2004: Jesús Avila; Mar Pérez; Filip Lim; Alberto Gómez-Ramos; Félix Hernández; José J Lucas
Tau in neurodegenerative diseases: tau phosphorylation and assembly.
Neurotoxicity research 2004;6(6):477-82.
2003: Miguel Díaz-Hernández; Félix Hernández; Ester Martin-Aparicio; Pilar Gómez-Ramos; María A Morán; José G Castaño; Isidro Ferrer; Jesús Avila; José J Lucas
Neuronal induction of the immunoproteasome in Huntington's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(37):11653-61.
2003: Félix Hernández; José J Lucas; Raquel Cuadros; Jesús Avila
GSK-3 dependent phosphoepitopes recognized by PHF-1 and AT-8 antibodies are present in different tau isoforms.
Neurobiology of aging 2003;24(8):1087-94.
2002: Félix Hernández; José I Borrell; Carmen Guaza; Jesús Avila; José J Lucas
Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments.
Journal of neurochemistry 2002;83(6):1529-33.
2002: Ester Martin-Aparicio; José J Lucas
[Molecular basis of Huntington's disease and possible pathogenic mechanisms].
Revista de neurologia 2002;35(3):212-20.
2002: Ester Martin-Aparicio; Jesús Avila; José J Lucas
Nuclear localization of N-terminal mutant huntingtin is cell cycle dependent.
The European journal of neuroscience 2002;16(2):355-9.
2002: Félix Hernández; Mar Pérez; José J Lucas; Jesús Avila
Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs.
Brain research 2002;935(1-2):65-72.
2002: Isabel Lastres-Becker; Fernando Berrendero; José J Lucas; Ester Martin-Aparicio; A Yamamoto; José A Ramos; Javier Fernández-Ruiz
Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease.
Brain research 2002;929(2):236-42.
2002: Félix Hernández; Filip Lim; José J Lucas; Concepción Pérez-Martín; Franscisco Moreno; Jesús Avila
Transgenic mouse models with tau pathology to test therapeutic agents for Alzheimer's disease.
Mini reviews in medicinal chemistry 2002;2(1):51-8.
2001: Filip Lim; Félix Hernández; José J Lucas; Pilar Gómez-Ramos; María A Morán; Jesús Avila
FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Molecular and cellular neurosciences 2001;18(6):702-14.
2001: Ester Martin-Aparicio; A Yamamoto; Félix Hernández; R Hen; Jesús Avila; José J Lucas
Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(22):8772-81.
2001: José J Lucas; Félix Hernández; Pilar Gómez-Ramos; María A Morán; R Hen; Jesús Avila
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
The EMBO journal 2001;20(1-2):27-39.
1999: José J Lucas; Félix Hernández; Jesús Avila
Nuclear localization of beta-catenin in adult mouse thalamus correlates with low levels of GSK-3beta.
Neuroreport 1999;10(13):2699-703.